Philadelphia Pharmaceuticals Company (ASE:PHIL)

ASE:PHIL Revenue

Philadelphia Pharmaceuticals Company had revenue of 2.08M JOD in the quarter ending September 30, 2025, a decrease of -3.47%. This brings the company's revenue in the last twelve months to 9.11M, up 1.83% year-over-year. In the year 2024, Philadelphia Pharmaceuticals Company had annual revenue of 8.76M with 4.25% growth.

• Revenue (ttm): 9.11M
• Revenue Growth: +1.83%
• P/S Ratio: 1.30
• Revenue / Employee: 70.64K
• Employees: 129
• Market Cap: 11.85M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.76M	357.51K	4.25%
Dec 31, 2023	8.40M	-10.46K	-0.12%
Dec 31, 2022	8.42M	1.81M	27.48%
Dec 31, 2021	6.60M	-1.05M	-13.77%
Dec 31, 2020	7.66M	-1.46M	-16.01%